𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

✍ Scribed by Ceresoli, Giovanni L.; Zucali, Paolo A.; De Vincenzo, Fabio; Gianoncelli, Letizia; Simonelli, Matteo; Lorenzi, Elena; Ripa, Cristina; Giordano, Laura; Santoro, Armando


Book ID
119320514
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
199 KB
Volume
72
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Gemcitabine and vinorelbine in pemetrexe
✍ Paolo A. Zucali; Giovanni L. Ceresoli; Isabella Garassino; Fabio De Vincenzo; Ra πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract ## BACKGROUND Pemetrexed‐cisplatin chemotherapy is the standard of care in the first‐line treatment of unresectable malignant pleural mesothelioma (MPM). Second‐line cytotoxic therapy is considered for a growing group of patients, but the optimal treatment has not been defined to date.